Moneycontrol
HomeNewsBusinessMarketsDAILY VOICE | Major pent-up demand in travel & hospitality which is likely to pick up with unlocking: Naveen Kulkarni of Axis Securities
Trending Topics

DAILY VOICE | Major pent-up demand in travel & hospitality which is likely to pick up with unlocking: Naveen Kulkarni of Axis Securities

The demand scenario will remain uncertain during the year. This could mean negative surprises in the growth rate while inflation continues to rise. Thus, there are real macro risks for the equity markets in the near to medium term, said Kulkarni

June 09, 2021 / 07:37 IST
Story continues below Advertisement

Naveen Kulkarni, Chief Investment Officer, Axis Securities, said that the unlock trade will be quite interesting this time, but it may not pan out exactly the same way as the last time. In the previous unlock theme, automobiles first performed then consumer discretionary while BFSI was the last to pick up.

Kulkarni has more than 15 years of experience in the financial services industry and specialises in fixed income markets, intermediation, origination, and distribution. Before joining Axis Securities, he served as the co-head of research at PhillipCapital India.

Story continues below Advertisement

In an interview with Moneycontrol's Kshitij Anand, Kulkarni said that some profit booking is advisable as earnings have not fully factored in the demand loss of Q1FY22. However, positives for many sectors have been factored in. Edited excerpts:

Q) The Nifty50 hit a fresh record highs in May and the momentum continued in June as well? What is your outlook on markets for 2021?

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show